IndustrialsSupport Services
  • Price (AUD)12.11
  • Today's Change0.12 / 1.00%
  • Shares traded1.83m
  • 1 Year change+24.21%
  • Beta1.2384
Data delayed at least 20 minutes, as of Nov 29 2021 05:10 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

ALS Limited is an Australian-based company, which is engaged in providing laboratory testing, inspection, certification and verification solutions. The Company operates through three segments: Life Sciences, Commodities, and Industrial. Its Life Sciences segment provides analytical testing, sampling services and remote monitoring for the environmental, food, pharmaceutical, and consumer product markets. Its Commodities segment provides testing services for the global mining industry in four business streams, which includes geochemistry, metallurgy, inspection, and coal quality. Its Industrial segment is a provider of diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. The Company operates from approximately 350 sites in over 65 countries across Africa, Asia, Australia, Europe and the Americas.

  • Revenue in AUD (TTM)1.95bn
  • Net income in AUD176.40m
  • Incorporated1910
  • Employees15.91k
  • Location
    ALS LtdLevel 2, 299 Coronation Drive, MiltonBRISBANE 4064AustraliaAUS
  • Phone+61 73367-7900
  • Fax+61 73367-8156
  • Websitehttps://www.alsglobal.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ALQ:ASX since
Investiga Pesquisas Clinicas LtdaDeal completed08 Mar 202108 Mar 2021Deal completed27.61%--
Data delayed at least 20 minutes, as of Nov 29 2021 05:10 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Milkyway Chemical Sply Chn Srvce Co Ltd1.53bn83.12m3.91bn2.66k45.685.83--2.552.372.3743.9618.551.4673.234.822,627,106.007.978.8613.7312.9010.4917.885.467.681.4212.550.343912.1641.6840.3447.1541.2327.00--
Luenmei Quantum Co Ltd762.83m275.79m4.05bn3.15k14.702.17--5.310.5490.5491.533.720.28114.023.121,104,481.0010.3612.7413.0616.4948.0252.4536.8544.002.49--0.171532.015.9415.335.9029.70-4.16--
China Automotive Engg Rsrch Inst Co Ltd794.38m156.68m4.26bn1.65k26.623.59--5.360.73710.73713.725.470.54665.394.272,190,319.0011.247.9614.109.5033.0128.7520.5716.711.93--0.050952.2324.0823.2319.6012.438.3824.57
CRISIL Ltd.409.83m76.14m4.27bn3.67k55.95--43.8910.4155.9755.97301.30--------5,972,507.00--20.82--29.29----18.5819.16--43.13--65.0814.447.513.134.465.9110.53
TechnoPro Holdings Inc2.03bn160.75m4.53bn21.69k28.016.5823.172.23120.49120.491,520.10512.891.44--7.897,549,051.0011.5811.0919.1617.6424.8624.888.037.35----0.294450.051.8412.3022.3612.47-10.2010.65
SMS CO.,LTD.461.32m67.24m4.70bn3.16k70.3114.2448.9710.2062.0162.01425.48306.170.701761.818.0612,412,200.0010.238.6814.3612.8688.8087.7614.5713.371.66--0.300616.352.3313.530.840316.2017.6522.10
Zhen Ding Technology Holding Ltd7.74bn458.27m4.73bn14.92k10.851.203.920.61039.139.13150.6382.530.91475.766.03--7.677.2014.0414.1920.1919.678.388.141.0516.820.281649.549.348.89-6.800.92422.860.00
Worley Ltd9.52bn86.00m4.90bn47.70k57.380.879213.340.51450.16290.162918.0810.640.8964--5.46199,496.900.80071.691.092.365.286.210.89321.66--4.210.2688122.98-27.054.10-50.0029.622.85--
Brii Biosciences Ltd0.00-842.52m5.68bn-----------6.63-6.630.00-8.01---------------------------3,272.484.06-------128.32------
Medlive Technology Co Ltd56.11m15.45m5.77bn356.00361.35144.51346.49102.830.12440.12440.45170.311------953,430.40--------72.97--27.54------0.0594--75.64--172.46------
ALS Ltd1.95bn176.40m5.78bn15.91k32.945.1920.042.960.3640.3644.032.310.7742--5.36122,781.507.055.089.506.10--89.379.117.400.80579.110.474778.35-4.997.29126.21--1.9311.34
CNOOC Energy Technology & Services Ltd8.37bn392.41m6.16bn15.12k15.701.38--0.73610.17580.17583.752.011.2041.083.522,521,323.005.94--8.98--12.03--4.94--1.57--0.0578---0.7621--23.40------
Wuchan Zhongda Group Co Ltd115.56bn732.10m7.65bn18.55k10.201.10--0.06620.65810.6581103.616.113.7814.0244.2528,377,490.003.813.9013.6011.382.822.801.011.090.698510.420.553550.9212.5517.2110.5418.2127.739.30
Data as of Nov 29 2021. Currency figures normalised to ALS Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

19.63%Per cent of shares held by top holders
HolderShares% Held
First Sentier Investors (Australia) IM Ltd.as of 19 Nov 202120.69m4.29%
Impax Asset Management Ltd.as of 30 Sep 202112.90m2.67%
The Vanguard Group, Inc.as of 05 Nov 202111.49m2.38%
Standard Life Investments Ltd.as of 31 Aug 20218.17m1.69%
Norges Bank Investment Managementas of 31 Dec 20207.85m1.63%
Vanguard Investments Australia Ltd.as of 31 Oct 20217.18m1.49%
Australian Foundation Investment Co. Ltd. (Invt Mgmt)as of 02 Jun 20217.01m1.45%
Credit Suisse Asset Management (Schweiz) AGas of 29 Oct 20216.88m1.43%
Invesco Advisers, Inc.as of 30 Sep 20216.47m1.34%
Milton Corp. Ltd. (Investment Management)as of 02 Jun 20216.08m1.26%
More ▼
Data from 31 Dec 2020 - 31 Oct 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.